Attend Jhpiego’s side-event, oral presentations, and poster sessions to learn about our expertise and innovative solutions aimed at preventing and treating malaria.
Jhpiego Attendees
Gladys Tetteh, Senior Technical Director for Malaria
Rima Shretta, Project Director, STOP-AMDR Project
Mark Kabue, Principal Technical Advisor for Measurement, Evaluation, Research, and Learning
Edward Kenyi, Technical Support Officer
Yemisi Ogundare, Project Director for Jhpiego Nigeria
Charity Anoke, Regional Senior Advisor for STOP-AMDR in Nigeria
Ndinda Kusu, Project Lead and Senior Malaria Advisor for Jhpiego Kenya
Nochiketa Mohanty, Director of Technical Excellence for Jhpiego India
Aristide Nacoulma, Regional Commodity Access Advisor for STOP-AMDR in Burkina Faso
Noella Umulisa, STOP-AMDR Project Lead for Jhpiego Rwanda
Marcel Manariyo, Senior Monitoring, Evaluation, and Learning Advisor
Meg Sreevatsava, Immunization Consultant
SCIENTIFIC SESSIONS
Join us at the sessions below to learn from our global health experts on diverse topics, from practical implementation approaches and innovative solutions to prevent and treat infectious diseases to leveraging digital health to improve awareness and behavior change.
Malaria Trends in Children Under Five Following RTS,S/AS01 Introduction in High-Transmission Districts of Burkina Faso
Antimicrobial Resistance Stewardship Integration Within Infectious Disease Programs Through an Integrated Quality Improvement Platform in Three Nigerian States
Using Malaria Testing and ACT Use Patterns in two selected states to design MFT Models to prevent ACT Resistance in Nigeria
Saturday, November 21, 2026 | 9:00 AM – 10:45 AM | Scientific Session 108
Beyond the Binary: Leveraging Vertical Programs for Integrated Antimicrobial Resistance Control
Sunday, November 22, 2026 | 8:30 AM – 10:15 AM | Scientific Session 157
SYMPOSIUM
ARTEMISININ PARTIAL RESISTANCE IN AFRICA: AN EMERGING ECONOMIC AND GLOBAL HEALTH SECURITY EMERGENCY
Projected economic and system-level consequences of widespread ACT failure in Africa (Rima Shretta, Jhpiego/Johns Hopkins University, US)
Friday, November 20, 2026 | 9:00 AM - 10:45 AM | Scientific Session 56
POSTER PRESENTATIONS
Operationalizing Multiple First-Line Therapies for Malaria: Implementation Research from the STOP-AMDR Project in Democratic Republic of Congo, Nigeria, Rwanda and Uganda
Poster Session A | Thursday, November 19, 2026 | 1:00 PM – 2:45 PM
Commodity Readiness for Initiating MFT Implementation: Lessons from Early Implementation in the 6 STOP-AMDR Project-Supported Countries
Poster Session A | Thursday, November 19, 2026 | 1:00 PM – 2:45 PM
Learnings from ACT Quantification During Early Stage of MFT Scale-Up in Burkina Faso
Poster Session A | Thursday, November 19, 2026 | 1:00 PM – 2:45 PM
Optimizing Malaria Case Management in Nigeria: Evidence from ACT Deployment Patterns in Enugu State
Poster Session A | Thursday, November 19, 2026 | 1:00 PM – 2:45 PM
Quantifying for New MFT ACTs and Related Resource Mobilization in Readiness for Sustained Availability and Successful MFT Implementation in Kenya
Poster Session A | Thursday, November 19, 2026 | 1:00 PM – 2:45 PM
From Resistance Signal to National Action: Operationalizing Multiple First-Line Therapies to Address Antimalarial Drug Resistance in Busia and Buikwe Districts, Uganda
Poster Session A | Thursday, November 19, 2026 | 1:00 PM – 2:45 PM
Drivers of Persistently High Malaria Incidence During the Low Transmission Season in Nanoro and Ténado Districts, Burkina Faso
Poster Session B | Friday, November 20, 2026 | 12:00 PM – 1:45 PM
Effect of household follow-up on ITN utilization in Burkina Faso
Poster Session B | Friday, November 20, 2026 | 12:00 PM – 1:45 PM
Tracking MFT Monitoring: Integrating ACT-Disaggregated Indicators into DHIS2 to Operationalize MFTs in Burkina Faso
Poster Session B | Friday, November 20, 2026 | 12:00 PM – 1:45 PM
Audit of Hand Hygiene Practices in Healthcare Facilities: Results from Three Regional Hospitals in Burkina Faso
Poster Session B | Friday, November 20, 2026 | 12:00 PM – 1:45 PM
Improving Vaccination Waste Management in Burkina Faso through a pooled subnational management model
Poster Session B | Friday, November 19, 2026 | 12:00 PM – 1:45 PM
Malaria Mortality at the Gaoua Regional Hospital: Investigation of Deaths and Priority Actions to Improve Care
Poster Session B | Friday, November 20, 2026 | 12:00 PM – 1:45 PM
Implementing Multiple First-Line Therapies to Address Antimalarial Drug Resistance in Rwanda: Early Experience from Four STOP–AMDR–Supported Districts
Poster Session B | Friday, November 20, 2026 | 12:00 PM – 1:45 PM
Integrating Multiple First-Line Therapies into National Forecasting and Supply Systems: Early Implementation Evidence and Scale-Up Planning from Uganda
Poster Session B | Friday, November 20, 2026 | 12:00 PM – 1:45 PM
From Evidence to Policy: Kenya’s Process of Developing a National Multiple First-Line Therapies (MFT) Strategy for Malaria
Poster Session B | Friday, November 20, 2026 | 12:00 PM – 1:45 PM
Bridging the community surveillance gap for antimicrobial resistance, baseline finding from a digital antibiotic reporting initiative in Nigeria
Poster Session B | Friday, November 20, 2026 | 12:00 PM – 1:45 PM
Performance of Community Health Workers and Associated Factors in the North and Far North Regions of Cameroon
Poster Session C | Saturday, November 21, 2026 | 1:00 PM – 2:45 PM
Impact of strengthening the integrated management of childhood illness (IMCI) at the community level on therapeutic coverage in Burkina Faso: a mixed-methods evaluation conducted in three regions
Poster Session C | Saturday, November 21, 2026 | 1:00 PM – 2:45 PM
Using Malaria Testing and ACT Use Patterns in two selected states to design MFT Models to prevent ACT Resistance in Nigeria
Poster Session C | Saturday, November 21, 2026 | 1:00 PM – 2:45 PM
Not coming to the ASTMH Annual Meeting? No problem. Join the conversation on social media.
Every dollar makes a difference. A gift of $10 can equip a delivery room, $30 can protect a newborn through routine immunizations, and $48 can provide a mother-to-be with four critical prenatal visits.